Authors: Dr. Aditya Singh, Prof. (Dr.) Vaseem A. Ansari, Prof. (Dr.) Juber Akhtar, Mr. Shubhrat Maheshwari
ISBN-13: 978-93-49554-47-4
Format: Paperback and e-book
Pages: 131
Product Dimensions: 6 x 9 inch
Publisher: Bharat Global Publications
Dr. Aditya Singh, a dedicated Lecturer at Integral University, Uttar Pradesh, India.
Prof. (Dr.) Vaseem A. Ansari, an eminent professor at Integral University, Lucknow, India, brings over 17 years of academic and research excellence with 50+ publications and 10+ granted patents in pharmaceutics and biotechnology.
Prof. (Dr.) Juber Akhtar, an accomplished academic and researcher with a Ph.D. from Integral University, currently serves Head of the Department at Integral University, Lucknow, India.
Mr. Shubhrat Maheshwari is a passionate researcher and emerging academician in the field of pharmaceutical sciences. He is currently pursuing his Ph.D. from the Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology, and Sciences (SHUATS), Prayagraj. Alongside his doctoral studies, he is working as a Junior Research Fellow (JRF) on a prestigious research project funded by the Department of Science and Technology – Science and Engineering Research Board (DST-SERB), Government of India.
Cancer remains one of the most challenging global health concerns, with its complex pathology and resistance to conventional therapies necessitating the development of innovative treatment strategies. In recent years, nanotechnology has emerged as a transformative approach in oncology, offering targeted drug delivery, enhanced bioavailability, and reduced systemic toxicity. Among the various bioactive compounds explored for cancer treatment, flavonoids have gained significant attention due to their potent antioxidant, anti-inflammatory, and anticancer properties. However, their clinical translation has been hindered by poor solubility, stability, and bioavailability.
This book, Advances in Flavonoid Nanoformulations for Cancer Treatment, delves into the latest advancements in nanotechnology-based delivery systems designed to overcome these limitations and optimize flavonoid-based therapeutics. It provides an in-depth exploration of various nanoformulations, including liposomes, dendrimers, polymeric nanoparticles, solid lipid nanoparticles, highlighting their mechanisms, efficacy, and potential for clinical applications.
The chapters in this book have been meticulously curated to encompass fundamental concepts, recent research findings, and future perspectives in the field. We aim to bridge the gap between preclinical research and clinical application by discussing the challenges, regulatory aspects, and translational potential of flavonoid nanoformulations in cancer therapy.
This compilation is intended for researchers, academicians, healthcare professionals, and students engaged in pharmaceutical sciences, nanomedicine, and oncology. By fostering a deeper understanding of flavonoid-based nanoformulations, we hope to contribute to the ongoing pursuit of more effective and safer cancer treatments.
We extend our sincere gratitude towards Integral University for providing a research platform and all the necessary facilities for conducting our studies. We also acknowledge the relentless efforts of scientists and clinicians worldwide who continue to advance the frontiers of cancer research.
We hope that this book will serve as a useful reference and inspire further innovation in the field of nanotechnology-driven cancer therapeutics.